# Ardelyx, Inc.: filings

ARDX · Nasdaq · CIK 1437402 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ardx.md) · [Financials](/companies/ardx/financials.md) · [Filings](/companies/ardx/filings.md) · [Insiders](/companies/ardx/insiders.md)

## Reports and events: 228 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 632, 8-K 153, 144 87, 3 50, SC 13G/A 39, 10-Q 37, SC 13G 21, S-8 15, DEFA14A 14, 10-K 12, DEF 14A 12, SCHEDULE 13G/A 12, CORRESP 11, UPLOAD 9, 424B5 8, EFFECT 7, SC 13D/A 7, S-3 6, 4/A 5, ARS 5, D 4, 5 3, S-1/A 3, SCHEDULE 13G 3, 144/A 2, CT ORDER 2, PRE 14A 2, 10-K/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, DEFR14A 1, DRS 1, FWP 1, S-1 1, S-1MEF 1, S-3/A 1, S-3ASR 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-17 | 16:05 ET | [8-K](/filings/0001193125-26-354026.md) | 8.01 Other events | 0001193125-26-354026 |
| 2026-08-06 | 16:12 ET | [10-Q](/filings/0001437402-26-000044.md) | Quarterly report, period 2026-06-30 | 0001437402-26-000044 |
| 2026-08-06 | 16:09 ET | [8-K](/filings/0001437402-26-000043.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437402-26-000043 |
| 2026-07-02 | 17:00 ET | [8-K](/filings/0001437402-26-000033.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437402-26-000033 |
| 2026-06-17 | 17:00 ET | [8-K](/filings/0001437402-26-000029.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001437402-26-000029 |
| 2026-04-30 | 16:05 ET | [10-Q](/filings/0001437402-26-000022.md) | Quarterly report, period 2026-03-31 | 0001437402-26-000022 |
| 2026-04-30 | 16:02 ET | [8-K](/filings/0001437402-26-000021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437402-26-000021 |
| 2026-04-29 | 16:01 ET | [DEF 14A](/filings/0001140361-26-017800.md) | Proxy statement, period 2026-06-16 | 0001140361-26-017800 |
| 2026-02-19 | 16:05 ET | [10-K](/filings/0001437402-26-000013.md) | Annual report, period 2025-12-31 | 0001437402-26-000013 |
| 2026-02-19 | 16:03 ET | [8-K](/filings/0001437402-26-000012.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437402-26-000012 |
| 2026-01-08 | 08:34 ET | [8-K](/filings/0001437402-26-000003.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437402-26-000003 |
| 2025-12-17 | 17:02 ET | [8-K](/filings/0001437402-25-000021.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437402-25-000021 |
| 2025-10-30 | 16:16 ET | [10-Q](/filings/0001437402-25-000018.md) | Quarterly report, period 2025-09-30 | 0001437402-25-000018 |
| 2025-10-30 | 16:09 ET | [8-K](/filings/0001437402-25-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437402-25-000016 |
| 2025-10-14 | 08:27 ET | [8-K](/filings/0001437402-25-000008.md) | 5.02 Departure or appointment of officers or directors | 0001437402-25-000008 |
| 2025-08-04 | 16:41 ET | [10-Q](/filings/0001628280-25-037464.md) | Quarterly report, period 2025-06-30 | 0001628280-25-037464 |
| 2025-08-04 | 16:22 ET | [8-K](/filings/0001628280-25-037441.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-25-037441 |
| 2025-07-03 | 08:49 ET | [8-K](/filings/0001628280-25-034132.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-034132 |
| 2025-06-18 | 17:23 ET | [8-K](/filings/0001628280-25-032172.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628280-25-032172 |
| 2025-05-01 | 16:04 ET | [10-Q](/filings/0001628280-25-021516.md) | Quarterly report, period 2025-03-31 | 0001628280-25-021516 |
| 2025-05-01 | 16:03 ET | [8-K](/filings/0001628280-25-021514.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-021514 |
| 2025-04-30 | 07:47 ET | [DEF 14A](/filings/0001140361-25-016522.md) | Proxy statement, period 2025-06-18 | 0001140361-25-016522 |
| 2025-04-29 | 08:02 ET | [8-K](/filings/0001628280-25-020477.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-020477 |
| 2025-02-20 | 12:08 ET | [10-K](/filings/0001628280-25-006653.md) | Annual report, period 2024-12-31 | 0001628280-25-006653 |
| 2025-02-20 | 07:34 ET | [8-K](/filings/0001628280-25-006564.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-006564 |
| 2025-01-13 | 08:04 ET | [8-K](/filings/0001628280-25-001246.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-001246 |
| 2024-11-18 | 16:04 ET | [8-K](/filings/0001628280-24-048258.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-048258 |
| 2024-10-31 | 16:06 ET | [10-Q](/filings/0001628280-24-044551.md) | Quarterly report, period 2024-09-30 | 0001628280-24-044551 |
| 2024-10-31 | 16:04 ET | [8-K](/filings/0001628280-24-044547.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-044547 |
| 2024-10-09 | 16:04 ET | [8-K](/filings/0001628280-24-042602.md) | 1.01 Entry into a material agreement | 0001628280-24-042602 |
| 2024-08-12 | 16:04 ET | [8-K](/filings/0001628280-24-036749.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-24-036749 |
| 2024-08-01 | 16:05 ET | [10-Q](/filings/0001628280-24-034121.md) | Quarterly report, period 2024-06-30 | 0001628280-24-034121 |
| 2024-08-01 | 16:03 ET | [8-K](/filings/0001628280-24-034110.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-034110 |
| 2024-07-02 | 07:04 ET | [8-K](/filings/0001628280-24-030708.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-030708 |
| 2024-06-17 | 09:01 ET | [8-K](/filings/0001628280-24-028413.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-028413 |
| 2024-05-23 | 16:58 ET | [8-K](/filings/0001628280-24-024996.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-024996 |
| 2024-05-02 | 16:05 ET | [10-Q](/filings/0001628280-24-019990.md) | Quarterly report, period 2024-03-31 | 0001628280-24-019990 |
| 2024-05-02 | 16:04 ET | [8-K](/filings/0001628280-24-019986.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-019986 |
| 2024-04-29 | 17:06 ET | [DEF 14A](/filings/0001140361-24-023095.md) | Proxy statement, period 2024-06-14 | 0001140361-24-023095 |
| 2024-03-05 | 16:21 ET | [8-K](/filings/0001628280-24-008908.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-24-008908 |
| 2024-02-22 | 16:40 ET | [10-K](/filings/0001628280-24-006393.md) | Annual report, period 2023-12-31 | 0001628280-24-006393 |
| 2024-02-22 | 16:04 ET | [8-K](/filings/0001628280-24-006321.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-006321 |
| 2024-01-08 | 08:04 ET | [8-K](/filings/0001628280-24-000772.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-000772 |
| 2023-11-13 | 16:06 ET | [8-K](/filings/0001628280-23-038599.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-038599 |
| 2023-10-31 | 07:03 ET | [10-Q](/filings/0001628280-23-035597.md) | Quarterly report, period 2023-09-30 | 0001628280-23-035597 |
| 2023-10-31 | 07:02 ET | [8-K](/filings/0001628280-23-035596.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-035596 |
| 2023-10-18 | 16:14 ET | [8-K](/filings/0001628280-23-034587.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-23-034587 |
| 2023-10-18 | 19:05 ET | [8-K](/filings/0001628280-23-034537.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-034537 |
| 2023-09-25 | 17:11 ET | [8-K](/filings/0001628280-23-032952.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-23-032952 |
| 2023-08-02 | 07:02 ET | [10-Q](/filings/0001628280-23-026569.md) | Quarterly report, period 2023-06-30 | 0001628280-23-026569 |

Page 1 of 5. [Older](/companies/ardx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.